Loading clinical trials...
Loading clinical trials...
Exploratory Clinical Study Evaluating the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With Recurrent/Refractory Light Chain Amyloidosis
Conditions
Interventions
BCMA CART
Locations
1
China
Beijing Gobroad Brond Hospital
Beijing, Beijing Municipality, China
Start Date
February 20, 2025
Primary Completion Date
September 30, 2027
Completion Date
September 30, 2027
Last Updated
May 21, 2025
NCT06971380
NCT05978661
NCT01789242
Lead Sponsor
Beijing Boren Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions